Saudis Move to Invest in Pharmaceuticals

RIYADH: Saudi Arabia's sovereign wealth fund on Sunday launched a commercial-scale contract development and manufacturing organization, Lifera, to help boost the local biopharmaceutical industry. The pharmaceutical investment company aims to focus on manufacturing life-saving and essential pharmaceutical products, including insulins, vaccines, plasma therapeutics, monoclonal antibodies, cell and gene therapies, and innovative small molecules, said an official statement. It seeks to bolster Saudi Arabia's position as a global pharmaceutical manufacturing destination. Yazeed A.